Forecasted Market Size 2015-2020

View All

Delveinsight
Outbreak of Companies Challenging New Pathways for Treatment of Pulmonary Arterial Hypertension

Drugs with better pharmacodymics and improved treatment algorithm with antiproliferative and anti-inflammatory treatments are needed! Pulmonary arterial hypertension (PAH) is rare lung disorder affecting pulmonary arteries. It is a fatal disease associated with the vasoconstriction and vascular remodeling that i...

Find More